Long Beach, CALIFORNIA4 Active Studies

Spinal Muscular Atrophy Clinical Trials in Long Beach, CALIFORNIA

Find 4 actively recruiting spinal muscular atrophy clinical trials in Long Beach, CALIFORNIA. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
1,578
Enrolling

Recruiting Spinal Muscular Atrophy Studies in Long Beach

RecruitingLong Beach, CALIFORNIANCT04155034

S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer

This phase III trial studies magnetic resonance imaging (MRI) surveillance and prophylactic cranial irradiation (PCI) to see how well they work compared to MRI surveillance alone in treating patients ...

668 participants
SWOG Cancer Research Network
View Study Details
RecruitingLong Beach, CALIFORNIANCT06875310

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

This is a trial to evaluate the efficacy, safety, and tolerability of adagrasib plus pembrolizumab plus platinum-doublet chemotherapy versus placebo plus pembrolizumab plus platinum-doublet chemothera...

630 participants
Mirati Therapeutics Inc.
View Study Details
RecruitingLong Beach, CALIFORNIANCT05468489

To Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC

This is a randomized, open-label study of Serplulimab plus chemotherapy (Carboplatin-Etoposide) in comparison with Atezolizumab plus chemotherapy in previously untreated US patients with ES-SCLC. Sub...

200 participants
Shanghai Henlius Biotech
View Study Details
RecruitingLong Beach, CALIFORNIANCT06095505

A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer

PUMA-ALI-4201 is a Phase 2 study evaluating alisertib monotherapy in patients with pathologically-confirmed small cell lung cancer (SCLC) following progression on or after treatment with one platinum-...

80 participants
Puma Biotechnology, Inc.
View Study Details

About Spinal Muscular Atrophy Clinical Trials in Long Beach

Spinal muscular atrophy (SMA) is a genetic neuromuscular disorder that causes loss of motor neurons, leading to progressive muscle weakness and atrophy. It is the leading genetic cause of infant death. Revolutionary gene therapies and SMN-enhancing drugs have transformed treatment.

There are currently 4 spinal muscular atrophy clinical trials recruiting participants in Long Beach, CALIFORNIA. These studies are seeking a combined 1,578 participants. Research is being sponsored by SWOG Cancer Research Network, Mirati Therapeutics Inc., Shanghai Henlius Biotech and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Spinal Muscular Atrophy Clinical Trials in Long Beach — FAQ

Are there spinal muscular atrophy clinical trials in Long Beach?

Yes, there are 4 spinal muscular atrophy clinical trials currently recruiting in Long Beach, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Long Beach?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Long Beach research site will contact you about next steps.

Are clinical trials in Long Beach free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Long Beach studies also compensate for your time and travel.

What spinal muscular atrophy treatments are being tested?

The 4 active trials in Long Beach are testing new therapies including novel drugs, biologics, and treatment approaches for spinal muscular atrophy.

Data updated March 2, 2026 from ClinicalTrials.gov